Action Pharma Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 10

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $110M

Action Pharma General Information

Description

Developer of novel drug candidates intended to treat cardiovascular, inflammatory, and metabolic diseases. The company's drug targets melanocortin receptors and brings these to the stage of clinical proof of concept for subsequent partnering, thereby enabling healthcare providers to prevent acute kidney failures in cardiac surgeries.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Brendstrupgaardsvej 102
  • 8200 Aarhus
  • Denmark
+45 45
Primary Industry
Drug Discovery
Acquirer
Vertical(s)
Corporate Office
  • Brendstrupgaardsvej 102
  • 8200 Aarhus
  • Denmark
+45 45

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Action Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 15-Jun-2012 $110M Completed Generating Revenue
6. Later Stage VC (Series D) 03-Jun-2010 Completed Generating Revenue
5. Later Stage VC (Series C) 01-Jan-2010 Completed Generating Revenue
4. Later Stage VC 17-Jan-2008 Completed Generating Revenue
3. Later Stage VC Completed Product Development
2. Later Stage VC 27-Oct-2006 $7.57M $7.57M Completed Product Development
1. Early Stage VC 01-Jan-2002 Completed Startup
To view Action Pharma’s complete valuation and funding history, request access »

Action Pharma Patents

Action Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2009074157-A1 Fully-modified phenyl pyrrole aminoguanidines Inactive 13-Dec-2007
WO-2009071101-A1 N-modified aminoguanidine derivatives Inactive 07-Dec-2007
EP-2045250-A1 Ring-substituted phenyl pyrrole aminoguanidine derivatives Inactive 26-Sep-2007
WO-2009039859-A1 Ring-substituted phenyl pyrrole aminoguanidine derivatives Inactive 26-Sep-2007
EP-2035373-A1 Phenyl pyrrole aminoguanidine derivatives Active 09-Jun-2006 C07D207/42
To view Action Pharma’s complete patent history, request access »

Action Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Action Pharma Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Capnova Venture Capital Minority
Global Life Science Ventures Venture Capital Minority
InnovationsKapital Venture Capital Minority
Inventure Capital (Denmark) Venture Capital Minority
Scandinavian Life Science Venture Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Action Pharma FAQs

  • When was Action Pharma founded?

    Action Pharma was founded in 2000.

  • Where is Action Pharma headquartered?

    Action Pharma is headquartered in Aarhus, Denmark.

  • What is the size of Action Pharma?

    Action Pharma has 10 total employees.

  • What industry is Action Pharma in?

    Action Pharma’s primary industry is Drug Discovery.

  • Is Action Pharma a private or public company?

    Action Pharma is a Private company.

  • What is the current valuation of Action Pharma?

    The current valuation of Action Pharma is .

  • What is Action Pharma’s current revenue?

    The current revenue for Action Pharma is .

  • How much funding has Action Pharma raised over time?

    Action Pharma has raised $42.1M.

  • Who are Action Pharma’s investors?

    Capnova, Global Life Science Ventures, InnovationsKapital, Inventure Capital (Denmark), and Scandinavian Life Science Venture are 5 of 6 investors who have invested in Action Pharma.

  • When was Action Pharma acquired?

    Action Pharma was acquired on 15-Jun-2012.

  • Who acquired Action Pharma?

    Action Pharma was acquired by Abbott.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process